India Molecular Diagnostic Controls Market, By Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender) - Industry Trends and Forecast to 2031.
India Molecular Diagnostic Controls Market Analysis and Size
Molecular diagnostic controls are essential for quality assurance in laboratory testing. They serve as standardized samples with known concentrations of specific nucleic acids or other molecular targets. Laboratories use these controls to validate and monitor the performance of their molecular diagnostic assays. Molecular diagnostic controls help assess the accuracy and precision of test results. By using controls with known concentrations of target biomolecules, laboratories can verify that their testing methods provide reliable and consistent results. Adherence to regulatory standards is crucial in the field of diagnostics. Molecular diagnostic controls are often required by regulatory agencies to ensure that laboratories meet quality and accuracy standards. Compliance with regulations helps maintain the integrity of diagnostic testing.
Data Bridge Market Research analyzes that the India molecular diagnostic controls market, which was USD 46.14 Million in 2023, is likely to reach USD 128.87 million by 2031 and is expected to undergo a CAGR of 13.7% during the forecast period. “Clinical laboratories” dominate the end user segment of the molecular diagnostic controls market due to the growing prevalence of infectious diseases.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
India Molecular Diagnostic Controls Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender) |
|
Country Covered |
India |
|
Market Players Covered |
Thermo Fisher Scientific Inc. (U.S.), ASURAGEN, INC.(U.S.), Merck KGaA (Germany), SERACARE LIFE SCIENCES (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Abbott (U.S.), Microbiologics (U.S.) |
|
Market Opportunities |
|
Market Definition
Molecular diagnostic controls are specific materials used in molecular diagnostic testing to ensure the accuracy, reliability, and precision of the results obtained from the testing process. Molecular diagnostics involves the analysis of genetic material, such as DNA or RNA, to detect and monitor various diseases, including genetic disorders, infectious diseases, and certain types of cancer.
India Molecular Diagnostic Controls Market Dynamics
Drivers
- Rising Incidence of Diseases
The rising prevalence of infectious diseases, genetic disorders, and chronic conditions is driving the demand for accurate and reliable diagnostic tests. Molecular diagnostic controls play a crucial role in ensuring the precision and reliability of these tests, contributing to effective disease management.
- Advancements in Molecular Diagnostics
Ongoing advancements in molecular diagnostic technologies, including polymerase chain reaction (PCR), nucleic acid sequencing, and other molecular techniques, are expanding the capabilities of diagnostic testing. The development of new assays often requires corresponding molecular diagnostic controls for validation and quality assurance.
Opportunity
- Rapid Growth of Point-of-Care Testing
The growth of point-of-care testing, where diagnostic tests are conducted near the patient rather than in a centralized laboratory, is increasing the demand for reliable molecular diagnostic controls. These controls are crucial for maintaining the accuracy of tests performed outside traditional laboratory settings.
Restraint/Challenge
- Stringent Regulatory Approval Processes
The regulatory approval processes for diagnostic controls can be lengthy and rigorous. Compliance with regulatory requirements is necessary for market entry, but it can pose a challenge in terms of time and resources. Delays in approvals may slow down the introduction of new molecular diagnostic controls to the market.
Recent Development
- In June 2021, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market
India Molecular Diagnostic Controls Market Scope
The molecular diagnostic controls market is segmented on the basis of product, analyte type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Independent Controls
- Instrument Specific Controls
Analyte Type
- Single Analyte Controls
- Multi Analyte Controls
Application
- Infectious Disease
- Oncology
- Genetic Testing
- Others
End User
- Clinical Laboratories
- Hospitals
- IVD Manufacturers & Contract Research Organizations
- Academic & Research Institutes
- Others
Distribution Channel
- Retail Sales
- Direct Tender
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The molecular diagnostic controls market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the molecular diagnostic controls market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on global the Molecular diagnostic controls market.
Competitive Landscape and India Molecular Diagnostic Controls Market Share Analysis
The molecular diagnostic controls market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the molecular diagnostic controls market.
Some of the major players operating in the molecular diagnostic controls market are:
- Thermo Fisher Scientific Inc. (U.S.)
- ASURAGEN, INC.(U.S.)
- Merck KGaA (Germany)
- SERACARE LIFE SCIENCES (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- bioMérieux SA (France)
- Abbott (U.S.)
- Microbiologics (U.S.)
SKU-
